Maiva Lifesciences gets nod for Rs 623-cr export-oriented unit in Krishnagiri, TNIllustrative image – not actual.

Maiva Lifesciences, a subsidiary of Maiva Pharma, has received the geen nod from the MEPZ SEZ Unit Approval Committee (UAC) to establish an export-oriented unit (EOU) in Krishnagiri, Tamil Nadu, at a cost of Rs 623 crore. The facility, to be located within the SIPCOT SEZ, Krishnagiri, will generate employment for 570 people.

This is part of a broader initiative by Maiva Pharma, which already has a presence in the area. The approval was granted during a meeting chaired by Alex Paul Menon, Development Commissioner of MEPZ SEZ. The committee reviewed 17 proposals across manufacturing, logistics, and service sectors, approving investments totaling Rs 712 crore. Of this, Rs 66 crore will go toward Special Economic Zones (SEZs), and Rs 646 crore toward EOUs, with Maiva Lifesciences accounting for the majority of the EOU investment.

Another key development was the approval of Kratonicals International, which committed to employing five transgender individuals, marking a significant step toward inclusivity and gender diversity within the SEZ framework.

← All latest storiesBack to top →